Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NYSE
Zymeworks Inc (ZYME)
Zymeworks Inc (ZYME) News

Zymeworks (ZYME)

Zymeworks Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ZYME

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
29/06/2023	20:12	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
21/06/2023	20:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ZYME	Zymeworks Inc
12/06/2023	20:26	Edgar (US Regulatory)	Amended Securities Registration (section 12(b)) (8-a12b/a)	NYSE:ZYME	Zymeworks Inc
12/06/2023	20:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
05/06/2023	10:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
02/06/2023	23:23	PR Newswire (US)	Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers	NYSE:ZYME	Zymeworks Inc
18/05/2023	12:41	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
16/05/2023	12:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
08/05/2023	21:20	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NYSE:ZYME	Zymeworks Inc
08/05/2023	20:14	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
28/04/2023	20:18	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NYSE:ZYME	Zymeworks Inc
26/04/2023	12:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
10/04/2023	20:46	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
15/03/2023	20:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
14/03/2023	21:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ZYME	Zymeworks Inc
07/03/2023	22:25	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NYSE:ZYME	Zymeworks Inc
07/03/2023	21:09	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
14/02/2023	21:47	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ZYME	Zymeworks Inc
14/02/2023	21:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ZYME	Zymeworks Inc
14/02/2023	19:38	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ZYME	Zymeworks Inc
10/02/2023	22:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NYSE:ZYME	Zymeworks Inc
25/01/2023	13:30	Business Wire	Zymeworks Announces Participation in Upcoming Investor Conferences	NYSE:ZYME	Zymeworks Inc
23/01/2023	23:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ZYME	Zymeworks Inc
19/01/2023	13:11	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
19/01/2023	12:45	PR Newswire (US)	Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma	NYSE:ZYME	Zymeworks Inc
19/01/2023	12:45	PR Newswire (US)	Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma	NYSE:ZYME	Zymeworks Inc
12/01/2023	21:48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ZYME	Zymeworks Inc
04/01/2023	21:22	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ZYME	Zymeworks Inc
04/01/2023	21:15	Business Wire	Zymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2023	NYSE:ZYME	Zymeworks Inc
03/01/2023	22:02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NYSE:ZYME	Zymeworks Inc

Showing the most relevant articles for your search:NYSE:ZYME

1 2 3 4 5 6 7 8 9 10 Next >>

Amundi Prime Global UCIT...

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions